Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-18F-fluoro-2-deoxy-d-glucose positron emission tomogram mediastinal staging | Zendy

Stephen Barnett | Zendy; JeanMarc Baste | Zendy; Kowsi Murugappan | Zendy; C. Tog | Zendy; Salvatore U. Berlangieri | Zendy; Andrew M. Scott | Zendy; Siven Seevanayagam | Zendy; Simon Knight | Zendy

Open Access

Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-18F-fluoro-2-deoxy-d-glucose positron emission tomogram mediastinal staging

Author(s) -

Stephen Barnett,

JeanMarc Baste,

Kowsi Murugappan,

C. Tog,

Salvatore U. Berlangieri,

Andrew M. Scott,

Siven Seevanayagam,

Simon Knight

Publication year - 2010

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2010.04.040

Subject(s) - medicine , thoracotomy , positron emission tomography , lung cancer , univariate analysis , standardized uptake value , chemoradiotherapy , surgery , pneumonectomy , radiology , radiation therapy , oncology , multivariate analysis

Prognostic information known preoperatively allows stratification of patients to surgery; induction therapy and surgery; or definitive chemoradiotherapy and may prevent a futile thoracotomy. Attention has focussed on the standard uptake value (SUV) of the primary tumour but less has been described regarding the 18F-fluoro-2-deoxy-D-glucose (18F-FDG) avidity of mediastinal nodes. We aimed, in a group of surgically resected cN0-1 but pN2 tumours, to compare the survival of patients with and without 18F-FDG avid mediastinal nodes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research